KJ Muldoon's Crispr Treatment Success
This is a IV news story, published by Wired, that relates primarily to Crispr news.
IV news
For more IV news, you can click here:
more IV newsCrispr news
For more Crispr news, you can click here:
more Crispr newsmedical innovations news
For more medical innovations news, you can click here:
more medical innovations newsWired news
For more news from Wired, you can click here:
more news from WiredAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
Crispr therapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Crispr medicine news, custom Crispr treatment news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Crispr treatmentWired
•Health
Health
A Baby Received a Custom Crispr Treatment in Record Time
70% Informative
KJ Muldoon has a rare disorder known as CPS1 deficiency, which causes ammonia to build up in the blood.
About half of babies born with it will die early in life.
A team at the Children’s Hospital of Philadelphia and Penn Medicine used Crispr to create a personalized medicine for KJ .
KJ is now able to eat certain foods and sit upright by himself.
KJ , a 27-year-old with Duchenne muscular dystrophy, passed away in 2022 shortly after receiving the first known custom Crispr treatment.
Researchers used a version of Crispr called base editing that can change one “letter” in a DNA sequence to another.
They packaged the Crispr components in tiny bubbles called lipid nanoparticles, which were then delivered via an IV infusion.
VR Score
62
Informative language
56
Neutral language
58
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links